<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD008457-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD008457-sec-0022"></div> <div class="table" id="CD008457-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings for the main comparison.</span>Â <span class="table-title">Summary of findings â chlorhexidine varnish</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Chlorhexidine varnish compared with placebo for the prevention of dental caries in children and adolescents</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> children and adolescents </p> <p><b>Settings:</b> school, nursery or dental clinic </p> <p><b>Intervention:</b> chlorhexidine varnish </p> <p><b>Comparison:</b> placebo </p> </td> </tr>
<tr class="table-header separated">
<td align="" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>No of Participants<br> (studies)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Placebo</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Chlorhexidine</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Caries in the primary teeth (24âmonths followâup)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"></td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Two trials with unit of analysis problem. Data imputations indicated no evidence to claim or refute a benefit </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Caries in permanent dentition (DMFS) (30 to 36 months)</b> </p> <p><b>Higher values indicate greater caries</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The mean increment in the control group was <b>5.82</b><sup>1</sup></p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p>The increment in the intervention groups was<br><b>0.53 higher</b> (1.53 higher to â0.47 lower) </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>â</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>690 (2)</p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>very low<sup>2</sup></b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Chlorhexidine varnish concentration 10% varnish and 40% varnish.</p> <p>A further three trials provided some unusable data but indicted no evidence to claim or refute a benefit<sup>3</sup></p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Elevated mutans streptococci levels</b> â¥<b>4 with caries screen (6 to 36 months)</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>620 per 1000<sup>4</sup></b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>577 per 1000</b> <br> (496 to 664) </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RR 0.93 (0.80 to 1.07)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>496 (1)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ââââ<br><b>very low<sup>5</sup></b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Chlorhexidine concentration 10% varnish</p> <p>Two other studies reported unusable data but indicated no evidence to claim or refute a benefit<sup>6</sup></p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"></td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>One study reported no adverse events for ulcers or tooth staining. One study stated âsideâeffects due to the CHX treatment were not noted" </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p>1. In the two trials that assessed this outcome, the DMFS increment in the control groups was 5.25 and 6.39, mean 5.82. This value was considered to be a moderate caries increment. </p> <p>2. We downgraded the quality of the evidence due to risk of bias (high and unclear risk of bias overall) and inconsistency. </p> <p>3. Conclusions reflected in remaining 3 studies (high risk of bias) with 6â to 24âmonths followâup and chlorhexidine concentrations of 1% and 10%, reporting caries outcomes in permanent dentition that could not be pooled in a metaâanalysis. </p> <p>4. In the single trial that assessed this outcome as presence or absence of high mutans streptococci levels, the prevalence of high mutans streptococci in the placebo varnish group was 62%. </p> <p>5. We downgraded the quality of the evidence due to risk of bias (unclear risk of bias overall), imprecision and inconsistency. Mutans streptococci outcomes were reported as mean mutans streptococci levels or presence or absence of high mutans streptococci. </p> <p>6. Equivocal results reported in 2 other studies (high risk of bias) with 6â to 24âmonths followâup and chlorhexidine concentrations of 1% and 10%, which could not be pooled in a metaâanalysis. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD008457-tbl-0002"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 2.</span>Â <span class="table-title">Summary of findings â chlorhexidine gel</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Chlorhexidine gel compared with no treatment for prevention of caries in children and adolescents</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> children and adolescents </p> <p><b>Settings:</b> all </p> <p><b>Intervention:</b> chlorhexidine gel </p> <p><b>Comparison:</b> no treatment </p> </td> </tr>
<tr class="table-header separated">
<td align="" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>No of Participants<br> (studies)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed risk</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>No treatment</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Chlorhexidine</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Presence of new caries in the primary teeth (24âmonths followâup)</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>16 per 1000</b><sup>1</sup></p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>16 per 1000</b> </p> <p>(6 to 45)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RR 1.00</b> (0.36 to 2.77) </p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>487 (2)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>ââââ<sup>2</sup><br><b>very low</b> </p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>Chlorhexidine concentration 0.12% gel</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>70 per 1000</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>70 per 1000</b> </p> <p>(25 to 194)</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Mutans streptococci prevalence</b> </p> <p><b>(24âmonths followâup)</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>180 per 1000</b><sup>3</sup></p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>227</b> </p> <p>(171 to 299</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RR 1.26</b> (0.95 to 1.66) </p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>490 (2)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>ââââ<sup>4</sup><br><b>very low</b> </p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>Chlorhexidine concentration 0.12% gel</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>466 per 1000</b><sup>3</sup></p> </td> <td align="" valign="" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>587 per 1000</b> <br> (443 to 774) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events (24âmonths followâup)</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"></td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="top" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Both studies reported there were no adverse events</p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><b>CI:</b> confidence interval; <b>DMFS:</b> decayed, missing and filled surfaces; <b>RR:</b> risk ratio </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p>1. Two trials assessed this outcome; the reported risk of caries in the control group was 1.6% and 6.9%. </p> <p>2. We downgraded the quality of the evidence due to risk of bias (we assessed both studies to be at high risk of bias overall), imprecision of the estimate due to low numbers of events in both the control and intervention groups, and indirectness (infants administered very low daily concentration). </p> <p>3. Two trials assessed this outcome; the reported risk of mutans streptococci in the control group was 46.6% and 18.1%. </p> <p>4. We downgraded the quality of the evidence due to risk of bias (we assessed both studies to be at high risk of bias overall), imprecision, and indirectness. </p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
